Naloxone Cloridrato Bambini S.A.L.F. (Naloxone Hydrochloride Dihydrate)

Naloxone works by competitively binding to μ‑opioid receptors with higher affinity than most opioid agonists. This displaces the opioid molecules, blocking their activity and quickly terminating the pharmacologic effects such as analgesia, sedation, and respiratory depression.

The specific dose of naloxone is determined by the prescribing clinician based on the severity of the opioid exposure, the route of administration, and the patient’s clinical response. Standard emergency protocols may guide initial dosing, but exact amounts are individualized.

Safety data for naloxone in pregnancy and lactation are limited. It should be used only when the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision should be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

The primary alternative to naloxone is naltrexone, another opioid antagonist. Naloxone has a rapid onset and a short duration of action, making it suitable for emergency reversal, whereas naltrexone has a longer half‑life and is used for maintenance therapy in opioid dependence. Their pharmacologic profiles and clinical uses differ accordingly.

Naloxone Cloridrato Bambini should be stored at 2‑8 °C in a refrigerator, protected from light. The vials must not be frozen or shaken. If temporary storage at controlled room temperature is unavoidable, the product should be used within the time frame specified by the manufacturer.

Naloxone is administered by a healthcare professional via intramuscular, intravenous, or subcutaneous injection. The route is chosen based on the clinical situation, with intramuscular injection often used in pre‑hospital settings and intravenous administration preferred in hospital environments for rapid effect.

Serious risks include cardiovascular arrhythmias, severe hypertension, seizures, pulmonary edema, and rare anaphylactic reactions. These events are uncommon but require immediate medical attention if they occur during or after naloxone administration.

Naloxone is contraindicated in individuals with known hypersensitivity to naloxone or any of its excipients. It should also be used with caution in patients with pre‑existing cardiac conditions, uncontrolled hypertension, or a history of severe seizures, and only under professional supervision.